Article
mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC
17 Oct 2024
Abstract excerpt
Background The aberrant expression of AEG-1 is significantly correlated with tumorigenesis, development, neurodegeneration and inflammation. However, the relationship between AEG-1 expression and immune infiltration in OSCC, as well as other tumor types, has yet to be comprehensively analyzed. Methods The expression levels, prognostic and clinicopathological characteristics, mutation patterns and methylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
